Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications
- PMID: 23089410
- DOI: 10.1016/j.phrs.2012.10.007
Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications
Abstract
Mammals and their intestinal microbiota peacefully coexist in a mutualistic relationship. Commensal bacteria play an active role in shaping and modulating physiological processes in the host, which include, but are not restricted to, the immune system and the intestinal barrier. Both play a crucial role in containing intestinal bacteria and other potentially noxious luminal antigens within the lumen and mucosal compartment. Although mutualism defines the relationship between the host and the intestinal microbiota, disruptions in this equilibrium may promote disease. Thus, alterations in gut microbiota (dysbiosis) have been linked to the recent increased expression of obesity, allergy, autoimmunity, functional and inflammatory disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). In this article, we review the evidence supporting a role of gut microbiota in regulating intestinal barrier function. We discuss the hypothesis that microbial factors can modulate the barrier in ways that can prevent or promote gastrointestinal disease. A better understanding of the role of the intestinal microbiota in maintaining a functional intestinal barrier may help develop targeted strategies to prevent and treat disease.
Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Irritable bowel syndrome: the role of the intestinal microbiota, pathogenesis and therapeutic targets.Acta Gastroenterol Belg. 2011 Sep;74(3):375-80. Acta Gastroenterol Belg. 2011. PMID: 22103040 Review.
-
Therapeutic modulation of intestinal dysbiosis.Pharmacol Res. 2013 Mar;69(1):75-86. doi: 10.1016/j.phrs.2012.09.008. Epub 2012 Sep 24. Pharmacol Res. 2013. PMID: 23017673 Review.
-
Alterations in intestinal microbial flora and human disease.Curr Opin Gastroenterol. 2008 Jan;24(1):11-6. doi: 10.1097/MOG.0b013e3282f2b0d7. Curr Opin Gastroenterol. 2008. PMID: 18043226 Review.
-
Gut microbiota and its pathophysiology in disease paradigms.Dig Dis. 2011;29(6):518-24. doi: 10.1159/000332975. Epub 2011 Dec 12. Dig Dis. 2011. PMID: 22179206 Review.
-
Intestinal microbiota in functional bowel disorders: a Rome foundation report.Gut. 2013 Jan;62(1):159-76. doi: 10.1136/gutjnl-2012-302167. Epub 2012 Jun 22. Gut. 2013. PMID: 22730468 Free PMC article.
Cited by
-
Role of Probiotics in Modulating Human Gut Microbiota Populations and Activities in Patients with Colorectal Cancer-A Systematic Review of Clinical Trials.Nutrients. 2021 Apr 1;13(4):1160. doi: 10.3390/nu13041160. Nutrients. 2021. PMID: 33915854 Free PMC article.
-
Impacts of Habitual Diets Intake on Gut Microbial Counts in Healthy Japanese Adults.Nutrients. 2020 Aug 12;12(8):2414. doi: 10.3390/nu12082414. Nutrients. 2020. PMID: 32806561 Free PMC article.
-
Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease.Adv Nutr. 2020 Jan 1;11(1):160-174. doi: 10.1093/advances/nmz080. Adv Nutr. 2020. PMID: 31399743 Free PMC article. Review.
-
Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.Nutrients. 2022 Dec 2;14(23):5140. doi: 10.3390/nu14235140. Nutrients. 2022. PMID: 36501169 Free PMC article. Review.
-
Oral administration of Lactobacillus rhamnosus GG to newborn piglets augments gut barrier function in pre-weaning piglets.J Zhejiang Univ Sci B. 2019 Feb.;20(2):180-192. doi: 10.1631/jzus.B1800022. J Zhejiang Univ Sci B. 2019. PMID: 30666850 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources